Joseph P. Pellegrino JR - 19 Dec 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chief Financial Officer, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
19 Dec 2021
Transactions value $
-$12,796
Form type
4
Date filed
21 Dec 2021, 16:32
Previous filing
14 Dec 2021
Next filing
27 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +15 +0.16% $0.00 9.25K 19 Dec 2021 Direct F1
transaction LMAT Common Stock Tax liability -$7.76K -161 -1.74% $48.21 9.09K 19 Dec 2021 Direct F2
transaction LMAT Common Stock Options Exercise $0 +6 +0.07% $0.00 9.09K 20 Dec 2021 Direct F1
transaction LMAT Common Stock Tax liability -$5.03K -106 -1.17% $47.49 8.96K 20 Dec 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -15 -29.41% $0.00 36 19 Dec 2021 Common Stock 15 Direct F4
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -6 -21.43% $0.00 22 20 Dec 2021 Common Stock 6 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.